![Congratulations to our 2024 Research Mentor Award recipients - American Gastroenterological Association Congratulations to our 2024 Research Mentor Award recipients - American Gastroenterological Association](https://gastro.org/wp-content/uploads/2023/09/Jean-Frederic-Colombel-300x300.jpg)
Congratulations to our 2024 Research Mentor Award recipients - American Gastroenterological Association
![ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well](https://medicalupdateonline.com/wp-content/uploads/2016/05/ECCO-2016-Part-1-Update-from-GEMINI-Study.jpg)
ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well
![1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023 1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023](https://www.hipaaspace.com/medical_billing/coding/national_provider_identifier/codes/npi_1356783989.png)
1356783989 NPI Number | JEAN-FREDERIC COLOMBEL M.D. | NEW YORK, NY | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023
![Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2023/02/TMM-IMMUNO-Jean-Frederic-Colombel-thumbnail.jpg)
Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY
![Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2022/02/TMM-IMMUNOLOGY-Jean-Frederic-Colombel-thumbnail.jpg)
Jean-Frederic Colombel, ECCO-IBD 2022: Upadacitinib in Ulcerative Colitis: Results from the UPA Phase 3 Programme - touchIMMUNOLOGY
![Helmsley Charitable Trust on X: "Jean-Frederic Colombel (@JeanFredericCo1) recently sat down with us to outline research strategies aimed at preventing #CrohnsDisease. Learn more about his work in our latest insight post: https://t.co/eb0kwPKlKL # Helmsley Charitable Trust on X: "Jean-Frederic Colombel (@JeanFredericCo1) recently sat down with us to outline research strategies aimed at preventing #CrohnsDisease. Learn more about his work in our latest insight post: https://t.co/eb0kwPKlKL #](https://pbs.twimg.com/media/GAnK_12WAAADzk3.jpg)